Skip to main content

Impact of the adequacy of antibiotic therapy on the outcome of ventilator-associated pneumonia

Introduction

The aim was to assess the impact of empiric antibiotic adequacy on ICU outcome of patients with ventilator-associated pneumonia (VAP), the reasons for inadequacy and risk factors for potential multidrug-resistant organisms.

Methods

During a 24-month period a multiple-centre observational study was conducted in five ICUs. Adult patients with documented VAP were segregated for analysis. Empiric antibiotic therapy was classified as adequate or inadequate according to in vitro efficacy against all isolated bacteria. The day of ICU discharge or death was recorded. Comparison between survivors and nonsurvivors was performed. Infection with potential multidrug-resistant organisms (methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa, Acinetobacter baumanii or Stenotrophomonas maltophilia) was evaluated for therapeutic inadequacy, ICU length of stay before diagnosis and previous use of antibiotics.

Results

One hundred and twenty-three patients with VAP (age 62.7 ± 16.9 years, 65.9% men, and SAPS II 49.5 ± 15.5) were identified. Empiric antibiotic therapy was adequate in 65.9%. These patients' ICU mortality was significantly lower in comparison with those with inadequate therapy (28.4% vs. 45.2%, P = 0.049). Patients infected with a potential multidrug-resistant organism were more likely to receive inadequate antibiotic therapy (80.1%, P = 0.001), and to have had longer previous ICU stay (11.5 days vs. 7.2 days, P = 0.005), but there was no difference in the previous use of antibiotics (65.2% vs. 50%, P = 0.102).

Conclusions

An empiric adequate antibiotic therapy was associated with a lower mortality rate in VAP. Multidrug-resistant organisms were significantly associated with therapeutic inadequacy and longer ICU length of stay.

Author information

Affiliations

Authors

Corresponding author

Correspondence to J Goncalves-Pereira.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Cite this article

Goncalves-Pereira, J., Sequeira, T., Moya, B. et al. Impact of the adequacy of antibiotic therapy on the outcome of ventilator-associated pneumonia. Crit Care 15, P220 (2011). https://doi.org/10.1186/cc9640

Download citation

Keywords

  • Antibiotic Therapy
  • Empiric Antibiotic Therapy
  • Stenotrophomonas Maltophilia
  • Acinetobacter Baumanii
  • Inadequate Therapy